Related Experiment Video
Updated: Jun 26, 2026
07:49
Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Mitochondria as targets for cancer therapy
1Genomic Research Centre, School of Medical Science, Griffith University, Southport, Qld, Australia.
Molecular Nutrition & Food Research
|January 6, 2009
Summary
Mitochondria are emerging as key targets for novel anticancer drugs called mitocans. These compounds selectively induce apoptosis in cancer cells by destabilizing mitochondria, offering a promising approach for diverse cancer types.
Area of Science:
- Mitochondrial biology
- Cancer therapeutics
Background:
- Mitochondria are crucial for cellular energy and apoptosis.
- Cancer exhibits genetic heterogeneity, challenging single-target therapies.
- Mitochondria are relatively mutation-free and a common cellular component.
Purpose of the Study:
- To explore mitochondria as a universal target for anticancer drug development.
- To investigate the potential of mitocans in cancer treatment.
Main Methods:
- Identification of compounds targeting mitochondrial function.
- Evaluation of mitocans' ability to induce apoptosis.
- Assessment of cancer cell selectivity.
Main Results:
- Mitocans destabilize mitochondria, triggering apoptosis.
- Apoptosis induction can be selective for cancer cells.
- Mitochondria represent a common target across different cancer types.
Conclusions:
- Mitochondria are a promising, invariant target for anticancer drugs.
- Mitocans offer a potential strategy for treating diverse neoplastic diseases.
- Targeting mitochondria may overcome challenges posed by cancer's genetic complexity.
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:37Mitochondria
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...